Population Screening for Liver Fibrosis Followed by Early Intervention. A Changing Paradigm in Hepatology
Pere Gines, Ph.D.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Describe the clinical important of chronic liver diseases worldwide as well as their etiological factors and natural history of cirrhosis and liver cancer.
• List the main risk factors related to development of chronic liver diseases.
• Describe non-invasive methods for assessment of liver fibrosis and their potential use for early diagnosis of hidden liver fibrosis in the population.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.